Reference
Du J, et al. Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification. Oncotarget 8: 26281-26287, No. 16, 2017. Available from: URL: http://doi.org/10.18632/oncotarget.15457 - China
Rights and permissions
About this article
Cite this article
Crizotinib. Reactions Weekly 1658, 147 (2017). https://doi.org/10.1007/s40278-017-32344-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-32344-9